Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of breast
|
3417 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.750 | 1.000 | 8 | 2011 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.750 | 1.000 | 11 | 2011 | 2019 | |||||
Systolic Pressure
|
1931 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.700 | 1.000 | 2 | 2018 | 2019 | |||||
Neoplasms
|
1644 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Carcinoma of lung
|
1204 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Coronary heart disease
|
1178 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Prostate carcinoma
|
1168 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of lung
|
1142 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Malignant neoplasm of prostate
|
1082 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Chronic Obstructive Airway Disease
|
852 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Diabetes Mellitus
|
824 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
ovarian neoplasm
|
757 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 2 | 2016 | 2017 | |||||
Glioma
|
353 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.700 | 1.000 | 3 | 2015 | 2018 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of ovary
|
315 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Chronic Lymphocytic Leukemia
|
291 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.800 | 1.000 | 2 | 2013 | 2019 | |||||
Renal Cell Carcinoma
|
288 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Glioblastoma
|
281 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 3 | 2015 | 2018 | |||||
Esophageal carcinoma
|
272 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Esophageal Neoplasms
|
270 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2013 | 2013 |